The role of the microbiome in health and disease involves complex networks of host genetics, 37 genomics, microbes and environment. Identifying the mechanisms of these interactions has 38 remained challenging. Systems genetics in the laboratory mouse enables data-driven discovery of 39 network components and mechanisms of host-microbial interactions underlying multiple disease 40 phenotypes. To examine the interplay among the whole host genome, transcriptome and 41 microbiome, we mapped quantitative trait loci and correlated the abundance of cecal mRNA, 42 luminal microflora, physiology and behavior in incipient strains of the highly diverse 43
Introduction 59
Although the human microbiome has been implicated as an important factor in health and 60 disease (Wen et al., 2008) , the mechanisms by which it influences human physiology are largely 61 unknown. Experiments that manipulate specific genetic, molecular and microbial components of 62 the microbe-host interface are essential to dissection of these mechanisms (Vijay-Kumar et al., 63 2010), but identification of targets for experimental manipulation remains a significant 64 challenge. However, both microbial community composition and its effects on host health are 65 modulated by host characteristics that exhibit heritable variation (Benson et were correlated using Kendall's Tau with the abundance of each OTU, revealing 45 significant 265 trait-microbe correlations (q< 0.05) (Storey, 2002) (Table 2) . Of the trait-microbe pairs, 41 266 contained sleep phenotypes that showed significant associations with 10 different microbes. 267
Among these, OTU 273 Odoribacter (ord. Bacteroidales, fam. Porphyromonadaceae) was the 268 bacterium consistently correlated to the largest number of phenotypes (21), and also significantly 269 correlated with decreased sleep time, among other sleep phenotypes (Table 2, Figure S4A ). 270
The Micab7 on chromosome 7 regulates the relative abundance of Odoribacter. The QTL 271 is 3.53 Mbp in size and contains 42 genes (Table 1) . The allelic effects for each of the eight 272 founder strain haplotypes are such that the NZO (New Zealand Obese) allele is associated withincreased abundance (Figure 4A-C) . This is significant because the NZO founder strain is obese 274 and prone to a diabetes phenotype, and previous studies of gut microbiota in obesity and diabetes 275 prone mice revealed that Odoribacter, Prevotella and Rikenella have been found in the 276 microbiota of diabetic db/db (BKS.Cg-Dock7 m +/+ Lepr db /J) mice and are absent among db/+, 277 +/+ littermates (Geurts et al., 2011) . The db/db mice have also been shown to have abnormal 278 sleep patterns in the form of altered sleep-wake regulation (Laposky et al., 2008 Figure 4E ). This relationship is 307 observed in the majority of graphs. Therefore there is a plausible interaction among the QTL, 308
Igf1r abundance, the leptin pathway, Odoribacter and sleep. 309
Broad spectrum antibiotic treatment alters sleep pattern in Lepr db / Lepr db mice. 310 We then evaluated whether the presence of Odoribacter in Lepr db mice could explain the 311 altered sleep behavior reported in these mice. To eliminate Odoribacter, mice were given 312 antibiotic treatment continuously from conception. As expected (Savage and Dubos, 1968) activity between 4 and 7 hour periods ( Figure 5E ), showed a significant genotype × treatmenteffect (F(3,120) = 12.2193, p < 0.0001) and individual LS Means Student t-test showed significant 320 differences between control db/db and all three other groups (Table S4 ). V4 sequencing of cecal 321 contents from db/db mice showed seven microbial taxonomic units that were absent in the 322 antibiotic treated case and elevated in the water vehicle controls, including the two from the 323 family containing Odoribacter ( Figure 5F ). Therefore, we conclude that Odoribacter abundance 324 influences sleep architecture in a manner regulated by genetic variation in Igf1r through the 325 In each of the above disease related studies, we utilized systems genetic networks to 408 identify, model and validate the relationships among host genetics, genomics, microbiota and 409 disease. The mouse provides an efficient, well-controlled system in which to employ this 410 approach, though it is amenable to application in human populations. We demonstrated that 411 using mouse genetics, we can identify relations that can be extrapolated to humans, though well-412 known issues in mechanistic conservation and direct translation must be considered. For 413 example, despite high conservation across human and mouse genomes, specific biological 414 mechanisms are not always entirely conserved, though the functional output of pathways and 415 involvement in disease may be. Our approach to this challenge is to exploit network overlap, to 416 identify elements of mouse networks that can be translated to human genetic and genomic 417 networks, which we expect to function similarly but perhaps differ in the details of specific 418 allelic variants, genetic mechanisms and particular microbiota involved. By developing our study 419 around holistic quantitation of both host and microbe, in contrast to typical studies of individual 420 perturbations and a specific focus on microbiota, we are able to generate broader networks 421 amenable to integration and extrapolation to disease mechanisms. Much remains to be done in 422 the functional validation of the conservation of these mechanisms. 423
In all studies of the interplay among host environment, microbiota and disease, the causal 424 mechanisms underlying associations must be considered. Genetic variation influences the host 425 environment creating conditions that are hospitable or inhospitable ecological niches for gut 426 microbiota. Identifying the precise causal genetic variants underlying microbial composition is a 427 lengthy process that has become more tractable with the advent of deep sequencing of the CC 428 founders, high precision mapping populations including the Diversity Outbred derived from the 429 CC, and the ability to integrate functional genomic data from other sources including epigenetic 430 modification, non-coding variants, and disease associations. 431
By exploiting genetic heterogeneity among organisms, we were able to extract 432 mechanistic relations among host, microbe and disease. The systems genetic strategy employed 433 herein provides a wealth of data resources that can be further interrogated by investigators with 434 an interest in specific host genes, variants, microbes and disease related phenotypes. 435
Furthermore, the strategy we present can be readily deployed in other genetically diverse 436 populations to provide efficient, holistic assessment of microbial and host mechanisms of 437 disease. Extracting these disease relevant mechanistic networks will provide insight into the 438 complex interplay of host and microbe, revealing potential sources of disease etiology and points 439 of therapeutic intervention. 
Supplementary material 524
Figure S1 Cecal microbial profile across mouse samples. Using 16S V4 rRNA gene sequence 525 reads, a majority of cecum microbes belong to the Firmicutes phylum followed by Bacteroides. 526
The other abundant phyla were Protobacteria (0.6%), Actinobacteria (0.6%).and Synergistetes 527 (0.3%) 528 Table S3 . GeneWeaver Gene Set IDs for sets of transcripts which are co-abundant with specific 556 microbial taxa. 557 Table S4 . Post-hoc comparison of mean sleep FFT peak amplitude in db/db and wild-type mice 558 treated with broad spectrum antibiotic or vehicle control. 
